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There is growing evidence that air pollution is a risk factor for a number of 
neurodegenerative diseases, most notably Alzheimer’s (AD) and Parkinson’s (PD).  It is 
generally assumed that the pathology of these diseases arises only later in life and 
commonly begins within olfactory eloquent pathways prior to the onset of the classical 
clinical symptoms.  The present study demonstrates that chronic exposure to high levels of 
air pollution results in AD- and PD-related pathology within the olfactory bulbs of children 
and relatively young adults ranging in age from 11 months to 40 years.   The olfactory 
bulbs (OBs) of 179 residents of highly polluted Metropolitan Mexico City were evaluated 
for AD- and alpha-synuclein-related pathology.  Even in toddlers, hyperphosphorilated tau 
(hTau) and Lewy neurites (LN) were identified in the olfactory bulbs.  By the second 
decade, 86% of the bulbs exhibited hTau (50/57), 76% LNs (45/57), 77% vascular amyloid 
(44/57), and 60% (34/57) mild diffuse amyloid plaques.  During the first two decades, OBs 
neurovasculature unit damage is associated with combustion-derived nanoparticles and 
myelinated and unmyelinated axonal damage was evident. OB hTau neurites were 
associated with pretangle stages 1a and 1b in subjects ≤20 years of age, strongly suggesting 
olfactory deficits could potentially be an early guide of AD hTau stages. Compared to non-
carriers, APOE4 carriers were 6 to 13 times more likely to exhibit OB vascular amyloid, 
neuronal amyloid accumulation, alpha-synuclein aggregates, hTau neurofibrillary tangles, 
and neurites.  Remarkably, within this data set the APOE4 carriers were 4.7 times more 
likely than non-carriers to have committed suicide.  The present findings, along with 
previous evidence that over a third of clinically healthy teens and young residents from the 
targeted pollution areas exhibit low scores on an odor identification test,  support the 
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concept that olfactory testing may aid in identifying young persons at high risk for 
neurodegenerative disease. Neuroprotective interventions in air pollution exposed 
individuals in the first two decades are critical. Air pollution control should be prioritized.  
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Introduction  
Exposure to air pollutants plays a major role in the development and/or acceleration of 
Alzheimer's disease (AD).1-8  Highly exposed Metropolitan Mexico City (MMC) residents 
show an early brain imbalance in genes involved in oxidative stress, inflammation, and 
innate and adaptive immune responses.9 Dysregulated neuroinflammation, diffuse brain 
neurovascular unit damage, the accumulation of misfolded proteins associated to the early 
stages of both Alzheimer's and Parkinson's diseases are seen in MMC youth and are absent 
in clean air controls. 2,3, 9-13   
Most of the literature associating air pollution to neurodegeneration is focused on 
Alzheimer’s disease, with a few papers making an association with Parkinson’s disease 
(PD).14-19 We have described both, AD and PD neuropathological hallmarks in young 
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MMC residents, including hyperphosphorilated tau and beta amyloid plaques in children as 
young as 11 months, 20 and alpha-synuclein in key brainstem nuclei and tracts.2, 10,12,13,21  
In a canine study comparing MMC dogs age 7 days to 10 years (n:26) versus clean air 
controls (n:14), nasal respiratory and olfactory epithelium were found to be early pollutant 
targets.22 Olfactory bulb and hippocampal apurinic/apyrimidinic (AP) sites in nasal and 
brain genomic DNA, were significantly higher in exposed v control age matched dogs. 22 
We previously described the olfactory bulb (OB) pathology in a cohort of 35 MMC vs 9 
controls ages 20.8+/-8.5 years assessed by light and electron microscopy.10 MMC residents 
showed with no exceptions OB vascular changes, neuronal accumulation of particles, 
and/or immunoreactivity (IR) to beta amyloid (29/35) and/or alpha-synuclein (4/35) in 
neurons, glial cells and/or blood vessels. 10 Combustion-derived nanoparticles (CDNPs) 
were documented in OBs endothelial cytoplasm and basement membranes. Control OBs 
were unremarkable. In the same work we also described the results of the University of 
Pennsylvania Smell Identification Test (UPSIT) administered to 62 MMC v 25 controls age 
21.2+/-2.7 years. Olfaction deficits were present in 35.5% MMC and 12% of controls.10 Of 
critical importance for the present work was the observation APOE 4 carriers failed 2.4+/-
0.54 items in the 10-item smell identification scale from the UPSIT related to Alzheimer's 
disease, while APOE 2/3 and 3/3 subjects failed 1.36+/-0.16 items, a highly significant 
result p=0.01. 10 
The OB is a perfect environmental target, participates in the brisk neuroinflammatory 
process upon exposures to polluted air where particulate matter and metals are key 
components, along with endotoxins and CDNPs. 5,10,22,24-30 We have described the 
association between olfactory bulb apurinic/apyrimidinic (AP) sites in genomic DNA- the 
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most frequently formed DNA lesions in the genome, evidencing contact with DNA-
damaging agents-, the presence of metals like Ni and V (from industrial environmental 
sources) in a gradient from olfactory mucosa > olfactory bulb > frontal cortex  and the 
significant OB neuroinflammation with upregulation of  IL1β  and COX2 in MMC residents. 
22, 30 Moreover, the clinical counterpart is seen in MMC children (13.4 ± 4.8 years, 28 
APOE 3 and 22 APOE 4). APOE4 children strongly failed to identify the soap odor in the 
UPSIT, strongly correlating with left hippocampus higher mI/Cr ratio. 31  
Urban polluted environments and occupational exposures with ubiquitous high 
concentrations of ultrafine particulate matter (UFPM, nanosize particles < 100 nm) are of 
great concern for the  nervous system due to the ease with which they penetrate biological 
barriers, including vascular endothelium, alveolar-capillary, olfactory, nasal, 
gastrointestinal, blood-brain-barrier (BBB) and blood-CSF barrier.3,5,11-13,20   
Combustion-derived nanoparticles (CDNPs) are composed of iron and associated transition 
metals, are highly oxidative and strongly magnetic.5 Such particles gain entry to the brain in 
significant amounts in young and older adult MMC residents and are known to cause severe 
damage to critical cellular organelles in the CNS in young urbanites.3, 5, 11, 13,20  
We have one primary aim for this study: To document in young urbanites by 
immunohistochemistry the early stages of the olfactory bulb pathological process 
associated with Alzheimer and alpha-synucleinopathies.  Electron microscopy is focused on 
the documentation of the vascular pathology, the identification and measurement of 
combustion-derived nanoparticles and the associated organelle pathology. We are 
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concerned about the olfactory bulb pathology progression with age and cumulative 
exposures to fine particulate matter (PM 2·5) above the USEPA standard.  
The early identification of olfactory AD and alpha-synucleinopathies pathology in 
air pollution highly exposed young individuals and the understanding the mechanistic 
pathways involved in the development of fatal neurodegenerative diseases are at the core of 
our research efforts. Identifying key air pollutants impacting early neural risk olfactory 
trajectories would greatly facilitate multidisciplinary prevention efforts for modifying the 
course of AD and alpha-synucleinopathies in pediatric and young adult ages.  
Methods 
Study design and samples  
One hundred and seventy-nine consecutive autopsies with sudden causes of death, not 
involving the brain were selected for this study. MMC subjects age 11 months to 40 years 
were clinically healthy prior to their sudden demise and were included in the study if: 
i. sections of olfactory bulb contain the anterior olfactory nucleus, granular, plexiform and 
glomerular layers and olfactory tract white matter, ii. gross examination of the brain was 
unremarkable, and iii. macro and microscopic examination of extra-neural key organs was 
unremarkable. Examination of autopsy materials was approved by the Forensic Institute in 
Mexico City. Autopsies were performed 4.1 ± 1.7 h after death between 2004-2008, and 
samples were collected by 4 trained researchers, weekdays, weekends and holidays during 
the 5 year study period. Brains were examined macroscopically, sections were selected for 
light and electron microscopy, and frozen tissues collected. The general characteristics of 
the study population, including their cause of death are seen in Table 1 (Suppl). An average 
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of 46±11 olfactory bulb slides were examined per case. Paraffin embedded tissue was 
sectioned at a thickness of 7 μm and stained with hematoxylin and eosin (HE). 
Immunohistochemistry (IHC) was performed on serial sections as previously described.2 
Antibodies included: β amyloid 17-24, 4G8 (Covance, Emeryville, CA 1: 1500), PHF-tau8 
(Innogenetics, Belgium, AT-8 1:1000), and α-synuclein phosphorylated at Ser-129, LB509 
(In Vitrogen, Carlsbad,CA 1:1000). Brain tissues included in this work were previously 
blindly investigated for purposes of AD. 20 Olfactory bulbs were examined for AD and 
alpha-synucleinopathies hallmarks.32-47 Tau pathology was scored using separate 
semiquantitative scores for neuropil threads (NTs) and neurofibrillary tangles (NFTs): 
0=absent, 0.5=very mild(only single lesions), 1= mild, 2= moderate, and 3= severe.36,38,39 
The β- amyloid scoring was semiquantitative: 0=absent, 1= mild, few diffuse Aβ positive 
areas, no plaques, 2= moderate, ≤3 plaques HPFx200, and 3= severe, 4 or more plaques 
HPFx200. 38 Intracellular Aβ  was scored 0=absent and 1= positive; vascular β- amyloid 
0,1,2 and 3 (severe). Alpha-synuclein was scored as follows:  0=absent, 1= mild, few Lewy 
neurites, no Lewy bodies 2= moderate, more than 1 Lewy body in a low power field, and 
sparce LNs; 3= severe, >1LBs and scattered LNs LPF and 4 very severe, numerous LBs 
and LNs. 40 Olfactory bulb tissue blocks were processed for EM 3 with a focus on the 
neurovascular unit and the target organelles of CDNPs.  Genotyping for the presence of 
APOE alleles polymorphisms was done as previously described.3 
Air Quality Data 
Metropolitan Mexico City residents are exposed year-round to fine particulate matter 
(PM2·5) and ozone (O3) concentrations above the United States National Air Ambient 
Quality Standards (NAAQS). For this study, we focused on <2.5μm particles and work 
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with cumulative PM2·5 (CPM2·5) above the annual USEPA standard: 12 µg/m3, reflecting 
lifetime exposures above the standard. Both, the PM2·5 annual standard and the 24-hr 35 
µg/m3 standard have been historically exceeded across the metropolitan area for the last 20 
years.23-25  
The accumulated burden of PM2.5 for each subject-including pregnancy-was calculated 
based on their urban residency.  Historical PM2.5 levels were obtained from a combination 
of particulate matter (PM) data from Mexico City Government Manual Monitoring 
Network for five representative urban sites: Tlalnepantla (NW), Xalostoc (NE), Pedregal 
(SW), Iztapalapa (SE) and Merced (downtown) (Figure 1) and an approach considering the 
typical PM2.5/PM10 ratio for each of the representative sites. Historically, the highest PM2.5 
concentrations occur in the NE sector where industrial and traffic activities are prevalent 
and decrease towards the SW residential area. We selected to work with a cumulative PM2.5 
(CPM2.5) exposure based on the assumption that long-term concentrations above the annual, 
averaged over 3 years USEPA standard of 12 µg/m3, would have detrimental health effects. 
To estimate the backward CPM2.5 we used the expression: 
    t 0 ,g/m 12-PM mean annualmax  PM C 32.52.5         
where the “max” function ensures only annual mean PM2.5 values are included. The 
backward summation was taken over the life time age (t) of each subject back to the 
prenatal period. The procedure was based on the assumption that the trend of PM2.5/PM10 
ratio obtained from the slopes of the correlations of these species in the period 2004-2010 
represent the backward PM2.5/PM10 ratios trends for previous years. The results compared 
well with a number of PM2.5/PM10 ratios reported by academic groups in conference 
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proceedings and published papers related to PM pollution in Mexico City in the 1980-
1990s.24-25 The resulting ratios were used to estimate the PM2.5 annual averages for each of 
the selected sites for the period 1989 to 2003. Since the study population included 
individuals older than 30 years at their time of death, we assumed a constant value for the 
PM2.5 annual averages prior to 1989 equal to the annual mean for this year. Overall, the 
PM2.5/PM10 ratios were relatively constant ranging from  0.45 in the Southwest towards  
0.25 in the Northeast. High PM2.5/PM10 ratios indicate a dominance of coarse particles in 
the PM10 while low ratios are associated to prevalence of fine particles.  
With the estimated PM2.5 annual averages for each site and year, we obtained a working 
annual average by averaging the 3 previous consecutive years according with the procedure 
to calculate the USEPA annual mean standard, moving backwards in time up to 30 years. 
The resulting working annual average was used to obtain the CPM2.5 with our equation for 
each of the individuals in the study, starting 1 year before their year of birth and up to the 
age of death (Table 1, Suppl). The working average data base was chosen according with 
the closest sampling site to their residence addresses during most of their life. 
Chemical PM composition studies in Mexico City have shown that the proportion of the 
different component PM species has not changed significantly along the years. 24-29 The 
PM2.5/PM10 ratio variations and the PM chemical composition are dependent on the site 
location and on the season. Typically, the coarse PM in MMC is strongly dominated by 
geological material (SiO2+CO2-3 +Al2O3+Ca+Fe+Mg+K) from dust resuspension. Organic 
and carbonaceous aerosols are the dominant species in the PM fine fraction. Particle 
emissions from gasoline and Liquefied Petroleum Gas Combustion (LPG) are dominated 
by organic carbonaceous aerosols (OC), while in diesel particles, black carbon (BC) is the 
10 
 
main component. 26 Organic aerosols in the air include primary hydrocarbon-like 
compounds, oxygenated organic compounds mostly secondary, organics from biomass 
burning, and small contributions of nitrogen-containing organics of primary combustion.27 
Also, critical for the brain effects, BC concentrations in PM2.5 have not shown a decrease 
through the years. 27 BC is associated with polycyclic aromatic compounds (PAHs), semi-
volatile species resulting from incomplete combustion of carbonaceous fuels such as 
gasoline and diesel vehicle exhaust gases.28   Most of PAHs in MMC are present in PM2.5. 
Trace metals in fine particles include Zn, Cu, Pb, Ti, Sn, Ba, Mn, Sb, V, Se, As, Ni, Cd, Cr 
in that order. 29 Zn, Cu, Ba, Pb, and Cd are tracers of road traffic, while V and Ni are tracers 
of industrial emissions. Exposures to ozone (O3) concentrations are also above the USEPA 
standards (annual fourth-highest daily maximum 8-hour concentration, averaged over 3 
years) all year long (Figure 1).  All other criteria pollutants for MMC, including nitrogen 
dioxide, sulfur dioxide and lead have shown elevated levels prior to 2000, but have been at 
or below the current EPA standards in the last 17 years.  
Statistical analysis  
Our sample size of 179 subjects was taken from a prior study of 203 subjects20 and it was 
defined a priori by sampling logistics in the 5 year study period balancing the expected 
results from previous neuropathology studies in young urbanites.2, 3, 12-13 We focused on 
summary statistics and graphical summary of the concerned staging variables: the major 
markers of Alzheimer and alpha-synucleinopathies (hTau, amyloid-β, α synuclein), age, 
gender, mode of death, and APOE status. Mode of death was analyzed in three major 
groups: accidents, homicides, and suicides. Subjects were divided by decades 1 and 2 (n: 
57) and 3 and 4 (n: 122). Figure 2 shows the comparison between the percentages of hTau 
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and amyloid-β phases in brain 20 versus olfactory bulb hTau NTs, NFTs, alpha-synuclein, 
Aβ in OB, vascular amyloid and intraneuronal amyloid.36,38-41-47 We also tested the 
relationship of the probability of committing suicide with respect to APOE status after 
adjusting age and CPM2.5 exposures. A goodness of fit test to check if the percentages of 
APOE4 in the suicide group and accident and homicide groups were the same. We 
identified APOE 4 carriers as individuals with higher suicide risk, and we performed 
logistic regression analysis to check if APOE 4 carriers had higher involvement of the 
targeted AD and alpha-synucleinopathies markers in the OB. We performed the statistical 
analyses using Excel and the statistical software ‘R’ (http://www.r-project.org/). 
Results 
Figure 1 and Table 1 (Suppl) show the annual mean averages of CPM2·5 for each individual 
based on their residence within arbitrary centroids in each of the five selected sampling 
sites. A polynomial regression of second degree was applied to the CPM2.5 data for each 
site. The regressions were overlapped on a figure of the estimated spatial distribution of the 
annual average PM2·5 concentrations in MMC for 2008. The insert in figure 1 shows the 
annual average of the daily ozone 8-h maximum for the same year.   
Figure 2 shows the comparison between the percentages of Htau and amyloid-β phases in 
brain versus olfactory bulb hTau NTs, NFTs, alpha-synuclein, Aβ in OB, vascular amyloid 
and intraneuronal amyloid by decades 1-2 and 3-4. The earliest finding in children are hTau 
NTs follow by LNs and NFTs later. Amyloid plaques, mostly diffuse and few, are 
stationary throughout the four decades, while amyloid neuronal accumulation and ɑ-Syn 
increased with age. In a model where CPM2·5, age and APOE status were included as 
suicide predictors, having an APOE4 significantly increases the odds of dying by suicide 
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4.57 times (p = 0.0025), and 13.1, 10.3, 9.8, 9.4 and 6.3 times higher odds of OB vascular 
amyloid, neuronal amyloid accumulation, ɑ Syn, hTau NFTs and NTs (all p < 0.0001) 
respectively, v APOE4 non-carriers having similar CPM2·5 exposure and age.  
Neuropathology 
The hTau and β amyloid brains’ scoring was done in a previous paper. 20 Both the olfactory 
bulb scoring for hTau NTs and NFTs, β amyloid, and ɑ-synuclein and the brain scoring are 
seen in Table 1 Suppl  
First decade findings 
The architecture of the OB layers in the 6 children ≤7 y, was largely preserved. However, 
there were significant variations in the definition of the layers, particularly the mitral/tufted 
and the glomerular layers (Figures 3 A, B). In addition, the size and compactness of the 
glomeruli varied significantly among children (Figures 3 B, C, D, H).  All six children were 
APOE 3/3 and all were classified in a previous work as pretangle stages a-c, 1a, 1b.20 hTau 
threads were seen in 5/6 children ages 11 months to 7 years, and a 3y old child had also 
vascular amyloid, Aβ42 immunoreactivity (IR) in neurons and glial cells around glomerular 
structures and diffuse amyloid positive areas (Figures 3 D, H). He also exhibited positive 
hTau and α-Syn IR (Figures 3 E, F, G). A two year old displayed isolated cells packed with 
particulate matter (Figure 3 B Insert).   
Second decade findings 
Disorganization of the OB layers and small, irregular and loose glomeruli, some with areas 
of calcification were striking findings (Figures 4 A, B, C, G, H, J,M).  The mitral cells were 
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difficult to define in relation to granular cell layers (Figures 4 A, H, I, M). Severe 
disruption of the granule cell layer was present in teens (Figure 4 M). The vascular changes 
become striking, with prominent endothelial cells and thick walls (Figure 4 A-C). We had 6 
subjects ≤ 20 years, with nuclear hTau involving the glomerular layers and the anterior 
olfactory nucleus (Figures 4 N, O, P), but very few hTau neurites in the AON (Figure 4 
INSERT P) or elsewhere. Eight-six percent had hTau mostly as threads or as small tangles 
(50/57), while 77.2% have vascular amyloid (44/57), and 60% (34/57) had mild diffuse 
amyloid plaques. Interestingly, we had 5 teens with no IR to hTau that had positive β 
amyloid either in blood vessels or neuronal. Lewy neurites and/or ɑ-Syn aggregates in the 
somatodendritic compartment were seen in 76% (43/57) of cases. It is important to note, the 
anterior olfactory nucleus (AON) was rarely involved in the deposition of abnormal 
proteins other that increased IR to neuronal amyloid and/or nuclear hTau (Figure 4 P, Q). 
However, we saw subjects with significant obliteration of the AON by corporae amylacea 
(Figure 4 R). In this age group, we did not see amyloid plaques or α-Synuclein in the AON, 
nor we saw Lewy bodies anywhere. A clear example of the severity of the aggregated 
abnormal protein deposition was an 11 y old boy APOE3 (#7 in Table 1 Suppl), resident in 
a SW borough, showing extensive β- amyloid and alpha synuclein (Figure 4 D, E,S ).The 
same child had accumulation of particulate matter in glomeruli neurons (Figures 4 G). 
Third and fourth decade findings 
Striking findings included extensive deposition of corporae amylacea (CA) in subjects 
carrying an APOE 4 allele (Figures 5 A, B, C, E). Disorganization of the OB layers with 
few irregular and small glomeruli were striking findings (Figure 5 D).The anterior olfactory 
nucleus in many cases was almost completely substituted by massive amounts of CA 
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(Figure 5 E).   hTau neurites and NFTs can be seen in glomerular and granular cell layers 
and white matter tracts (Figures 5 F, G, H). Alpha-synuclein is seen as Lewy neurites and 
aggregates in the somatodendritic compartment (Figure 5 I, J), but few distinguishable 
core-and-halo appearance Lewy bodies. Amyloid plaques, intracytoplasmic neuronal 
accumulation, and vascular amyloid pathology were frequent findings (Figure 5 K). 
One micron Toluidine blue sections and Electron Microscopy  
One micron toluidine blue and electron microscopy findings were striking in relation to 
damage to unmyelinated and myelinated axons  and blood vessels with abnormal basement 
membranes and hyperplastic smooth muscle cells in young teens (Figure 6 A-D). Extensive 
accumulation of lipofuscin distinguished APOE 4 from APOE3 carriers (Figure 6 C, D,E). 
The endothelial cell (EC) erythrophagocytosis was particularly prominent in APOE 4 
children (Figure 6 G, H, I). Clusters of nanoparticles were common between red blood cells 
in capillaries (Figure 6 J, K). Children and teens also show significant accumulation of 
lipofuscin (Lf) in endothelial cells, pericytes, smooth muscle cells, and neurons. Abnormal 
neurovascular units were noted, and isolated beta pleaded sheet helicoidal conformation 
fibers (Figure 6 F) were observed along with CDNPs of sizes ranging from 9-60 nm. 
Extensive loss of unmyelinated and myelinated axons is seen in teens and young adults 
(Figure 7 A-C).The few surviving myelinated axons exhibit numerous CDNPs in their 
myelin sheets (Figure 7A). CDNPs are seen within neurons and glial cells in target 
organelles including mitochondria, endoplasmic reticulum (ER), mitochondria-ER contacts 
(MERC) as well as in nuclear chromatin (Figures 7 B-J). CDNPs are present in damaged 





Damage to the olfactory bulb (OB) in young Metropolitan Mexico City residents is early, 
progressive, exhibits Alzheimer and alpha-synucleinopathies hallmarks, and the damage is 
particularly severe in APOE 4 carriers. The neuropathology in children and teens strongly 
suggests the OB is an unavoidable target of pollution and nanoparticles likely play a critical 
role. The neurovascular unit 48 is an early, critical target and active endothelial 
phagocytosis of RBC fragments containing combustion-derived nanoparticles (CDNPs) is 
an ongoing phenomenon. The significant vascular and extensive damage to unmyelinated 
and myelinated axons in the olfactory tracts and the hallmarks of the most prevalent 
tauopathies and synucleinopathies, obligates us to consider the olfactory bulb as a sentinel 
for evolving neurodegenerative processes. Strong support for pediatric and young adults 
olfactory testing is an expected outcome of this work.   
The OB presence of β-amyloid, abnormal tau and ɑ-synuclein pathology have been 
described by our classic neuropathologists. 32-47 The strong association of 
neurodegenerative OB pathology with olfaction deficits and targeted neuronal groups are 
also well known.49-54 A key concept in this discussion was put forward by Spires-Jones et 
al., 55 “Neurodegenerative diseases such as Alzheimer’s disease, Lewy body disease (LBD), 
Parkinson’s disease (PD) …have in common that protein aggregates represent 
pathological hallmark lesions”. We are indeed describing an overlap of hallmarks for AD, 
PD, LBD, etc., in megacity residents, suggesting that in the setting of air pollution we 
ought to have common etiopathology denominators. Alzheimer’s pathology in the olfactory 
bulb is present in the majority of patients with neuropathologically confirmed AD.38  In 
Attems et al., study of 536 autopsies (232 controls) with a mean age of 81.3±0.46 years, 
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33.8% had a confirmed AD diagnosis. The AD cases showed OB hTau in 98. 3%, 51.7% 
had Aβ and 34.4% ɑ-Syn pathology. 38 In controls (n: 232), hTau pathology was present in 
47.1%, ɑ-Syn in 28.6% and Aβ pathology in 3.5%. Clinically demented cases in Attems et 
al., work showed significantly higher OB hTau, Aβ and ɑ-Syn scores than non-demented 
cases.38 In Tsuboi et al., work, anterior olfactory nucleus (AON) hTau pathology was 
absent in the lower Braak stages and progressively increased to a 100% involvement in 
stages V and VI. 34 hTau AON pathology was very rare in their 15 controls with no 
significant neurodegenerative pathology.34 In their LBD cases, 77% had ɑ-Syn in the AON 
and ɑ-Syn AON pathology was only rarely detected in the absence of concomitant hTau 
pathology. 34 Tsuboi et al., also discussed that APOE4 correlated with the severity of tau 
pathology in the AON in a gene dose-dependent manner. 34  
In sharp contrast to the OB pathology described in advanced Alzheimer’s, LBD and 
Parkinson’s disease elderly patients 32-34, 36-47,56, MMC young residents exhibited hTau in 
the axon initial segment (AIS) and in neurites as the very first OB tract findings, followed by 
ɑ-Syn neurites in the glomerular and granular cell regions and the OB tracts. A striking 
finding –previously described in MMC exposed toddlers and teens in brainstem and 
supratentorial neurons, ependymal and endothelial cells20- was the presence of nuclear 
hTau in neuronal glomerular and granular layers and the AON in teens. The nuclear hTau 
would fail to efficiently protect DNA from oxidative stress as commented by Sultan et al., 
it will contribute to functional failure of neurons early in life.57 The Aβ pathology in the 
form of diffuse plaques was mostly mild and remained very stable throughout the first 4 
decades of life.  
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It is important to emphasize, the AON was not a target of Htau and/or ɑ-Syn in the first 4 
decades, strikingly however, the increase in AON corporae amylacea was significant, 
particularly in APOE4 carriers. A key finding was the accelerated OB pathology course 
relative to Braak early subcortical stages a-c, cortical lesions stages 1a, 1b, I and II and 
NFT stages45, thus in the first two decades when the majority of children and teens exhibit 
pretangle stages 1a and 1b, 84% have already OB hTau neurites (Figure 2), strongly 
suggesting olfactory deficits could be an early guide of early AD hTau stages.  
ɑ-Syn is a different story, we have described LNs in brainstem and ENS in children, 12, 13 
coinciding with the early OB ɑ-Syn neurites in 68% of subjects in the first two decades. 
MMC children would be at Lewy pathology stages 1 and 2 according with the distribution 
of Lewy pathology in sporadic Parkinson’s disease in Del Tredeci and Braak work. 41   This 
PD staging is critical because we are recording autonomic symptomatology in > 60% of the 
young adult MMC population ages 20.5±1.08 (Personal communication: Nora Vacaseydel-
Aceves and Samuel C. Luévano-Castro, April 9, 2018). 
The ɑ-Syn OB location is important given the work of Ubeda-Bañon, Saiz-Sánchez and 
Markram et al., groups. 50-52, 58 Axons of sensory olfactory cells make synapsis with apical 
dendrites of mitral and tufted cells-the principal cells in the OB- in the glomeruli. 
Interneurons constitute 20-30% of the neuronal OB population, mostly granule or 
periglomerular cells. 58 These regions are precisely the location of the first LB neurites we 
observed in MMC youngsters, while the tertiary structures are not yet involved. Tertiary 
olfactory-recipient structures 59 including the AON in their bulbar, intrapeduncular and 
retrobulbar portions are significantly involved in PD, LBD and AD 35,38,52, 60-63  
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A key element of vasopathology in the OB is the endothelial engagement  in 
erythrophagocytosis.64 The circulating RBC are innate carriers tolerating millions of 
nanoparticles under experimental conditions, and having  biocompatibility, low 
immunogenicity, flexibility, and long systemic circulation. 65-67 RBC are exposed to 
oxidative stress related to iron containing magnetite nanoparticles 3, 5, 20, 68, 69 with the 
detrimental combination of high redox activity, surface charge, and strongly magnetic 
behavior. Experimentally, RBC carrying NPs can get in close proximity to the endothelial 
surface and binding takes place, this is very important in highly exposed air pollution 
residents because endothelium adhesion efficiency of RBC increases with their enhanced 
phosphatidylserine exposure. 70-72 To complicate matters, the phosphatidylserine exposure 
by RBC is a powerful signal that initiates their phagocytic removal from circulation, a 
process that normally takes place in liver and spleen. Fens et al., 64 discussed a very similar 
scenario when they exposed their RBC to oxidative stress, erythrophagocitosis was a 
common event with the resultant cytotoxicity. Fens et al., suggested and we fully agreed 
“significant erythrophagocitosis can induce endothelial cell loss….”64 and a major damage 
to the OBs neurovascular unit. Why is this issue very relevant to city dwellers? Because 
odor stimulation induces capillary vascular responses that according to Chaigneau et al., are 
odorant and glomerulus-specific in rats. 73 Thus, since the responses will either increase or 
decrease RBC flow and in turn proper capillary vascular responses relate to synaptic 
activation, abnormal RBC and sticky endothelium will have detrimental glomeruli synaptic 
activation.  
Since nanoparticles are ubiquitous in OBs, factors related to access and transportation of 
NPs and aggregation and propagation of abnormal proteins in the OB and elsewhere in the 
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CNS and ENS are important. 74-81   Size, shape, surface charge and chemistry, chemical and 
biocorona composition, and solubility of NPs will be key in their degree of cytotoxicity and 
genotoxicity, their capacity to cause damage to target organelles and to produce 
aggregation and propagation of abnormal proteins in nervous tissues. Recently described 
nanocluster aerosol particles emitted by road transportation (1.3-3.0 nm) potentially acting 
as nanosized condensation nuclei for the condensation of atmospheric low-volatile organic 
compounds, ought to be of great concern for OBs damage.75 Sintov et al.,76  summarize 
three pathways involved in the transport of NPs through the OB i. axonal transport, ii. 
transcellular transport across the supporting cells in the olfactory region, iii. paracellular 
diffusion between supporting and neural cells. In the work of Wang et al., 79   35-50 nm 
Fe2O3 NPs instilled intranasally, were readily located by TEM in the axons of olfactory 
neurons and in mitochondria and lysosomes of hippocampus cells in exposed mice. In the 
work of Alvarez et al.,74 gold NPs produced a strong acceleration of ɑ-synuclein 
aggregation, the effects were dependent on the NPs size and concentration, being strongest 
for NPs 10 nm in diameter, which produced a 3-fold increase in the overall aggregation rate 
at concentrations as low as 20 nM. Since the NPs identified in Mexico City residents are 
iron highly magnetic NPs 5 the work of Xie et al., 80 describing oxidative stress, lipid 
peroxidation and depletion of superoxide dismutase (SOD), glutathione, and catalase 
(CAT) activities upon iron oxide NPs exposures is very relevant to OBs damage. An 
additional factor of great interest would be magnetic fields. Min et al., 81 argue that the rate 
of iron NP uptake and transport across cell monolayers is enhanced by a pulsed magnetic 
field and significantly inhibited at low temperature under both constant and pulsed 
magnetic field conditions, consistent with an active mechanism such as endocytosis, 
mediating NP transport. Thus, environmental exposures to pulsed magnetic fields could be 
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another factor in the equation to compare transport and damage of iron oxide NPs across 
populations. 
 
We have described different sizes of NPs in different neural regions both in humans and 
dogs, so size matters.3,13,20,68 In the current OB study measurable NPs were in the range of 
9-60 nm, thus included sizes ~10nm, very efficient in α-synuclein aggregation.74 
The relationship between APOE4 status, suicide risk, depression, olfaction deficits, and 
cumulative PM2.5 deserves extensive research.20 We found APOE4 carriers have 4.57 times 
higher suicide odds, and higher odds of OB AD and ɑ Syn pathology. These findings are 
critical for several reasons: i. We fully expect a relationship between the OB 
neuropathology and olfactory deficits, a relationship that is clear in older populations with 
both AD and alpha-synucleinopathies.33,34,36,38,53,63   ii. There are a significant number of 
papers on depression, OB size, and emotions.82-86 The key question is how many young 
subjects with olfaction deficits, depression and altered emotional responses are already in 
their way to AD or PD/DLB? 
Finally, there is an issue we are obligated to discuss: what is the ultimate 
importance of the OB neuropathology spectrum in young highly exposed individuals and 
without any significant extraneural pathology? There is clear evidence of neurovascular 
unit damage with increased lipofuscin (Lf) as a striking finding. Lf formation is driven by 
ROS, is an intralysosomal, non-degradable, auto-fluorescent macromolecule which under 
physiological circumstances accumulates with age and can affect autophagy - the lysosomal 
degradation of a cell's constituents.87 McElnea et al., 87 make a statement that is applicable 
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to the OB in exposed air pollution populations: intracellular lipofuscin accumulation may 
have important effects on autophagy. Indeed, Lf relates to the rate of oxidative damage to 
proteins, the functionality of mitochondrial repair systems, the impairment of proteasomal 
systems, and the functionality and effectiveness of the lysosomes. 88, 89 The issue of the 
autophagy-lysosome pathway (ALP) regulating intracellular homeostasis of the cytosolic 
protein SNCA/alpha-synuclein has been discussed by Minakaki et al., 90 Inhibition of the 
ALP increases fused multivesicular body-autophagosome compartments and the 
"autophagosome-exosome-like" profile and alters the intracellular homeostasis of the 
cytosolic protein SNCA/alpha-synuclein. Why is Minakaki et al., outstanding work relevant 
to us? Because is precisely this autophagy-lysosome pathway that is impaired in alpha-
synucleinopathies, including PD and DLB.90 Moreover, iron promotes α-Syn aggregation 
and transmission. 91 Xiao et al., results are very relevant to our findings (Fe and assorted 
metals-containing nanoparticles) demonstrated that iron promoted α-synuclein aggregation 
and transmission by inhibiting autophagosome-lysosome fusion. Further, Fe decreased the 
expression of nuclear transcription factor EB, a transcriptional regulator of autophagosome-
lysosome fusion, and inhibited its nuclear translocation through activating AKT/mTORC1 
signaling.91 Thus, we have a distinct plausible pathway for α-synuclein aggregation and 
transmission.91 
Corporae amylacea (CA) -glycoprotein-based deposition- in significant numbers were also 
an outstanding OB finding.92 In the work of Pirici et al., the three-dimensional structure of 
CA is complex with branching exhibiting a direct correlation with the diameter of vessels, 
while perivascular CAs are enclosed in pockets of the basement membranes. Interestingly, 
endogenous astrocytic heme oxygenase-1 (HO-1)-a cytoprotective enzyme-, reported to be 
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localized in mitochondria under stress and contributing to preserve mitochondrial function, 
promotes transformation of normal mitochondria to CA-like inclusions.93 Thus, several 
potential CA production pathways could be at work in OBs exposed to hostile conditions. 
Since the study subjects are young, age certainly is not a factor, in consequence 
neurodegenerative conditions have to be at play.94, 95 
There is no question we are seen AD and PD/DLB olfactory bulb hallmarks, along with 
increased lipofuscin and corporae amylacea.  This overlap is what we see as 
neuropathologists in a demented patient or in a presumably cognitively intact elderly 
control.  Braak and Del Tredeci commented about the spectrum of Lewy Body diseases and 
the fact cognitive impairment precede dementia in sporadic PD patients 42 Also there is 
plenty of literature about the overlap between vascular disease and tautopathies and alpha 
synucleinopathies and the impact of vascular risk factors upon PD dementia and dementia 
with Lewy Bodies versus AD. 96-99 Love and Miners100 commented on a major contributor 
to the progressive hypoperfusion seen in AD: endothelin-1 (ET-1)- a marker of endothelial 
damage significantly increased in Mexico City children. 101-102 ET-1 levels in MC children 
are positively strongly correlated with daily outdoor hours, and 7-day cumulative levels of 
PM air pollution < 2.5 um. 102 Thus within the context of ET-1 vasoconstriction and the 
neurovascular unit damage, both increased cerebrovascular resistance and loss of neurally-
mediated vasoreactivity could also play a role in the hypoperfusion effects.103-104 
Our findings have several limitations: there is an overrepresentation of males, thus we are 
unable to discuss how the OB pathology progresses in females. Since we had no means of 
assessing olfactory and neurological data, the direct association with OBs pathology is not 
possible. This lack may have led to relevant olfactory, psychiatric, behavioral, and 
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neurotoxic exposure information. On the other hand, based on our clinical studies we know 
about the olfaction deficits, their relationship with metabolic brain changes, the extensive 
cognitive deficits, their systemic inflammation, endothelial dysfunction, etc., in a 
comparable healthy population .10,31, 54,101,102 
We strongly support a complex overlap of tautopathies and alpha-synucleinopathies 
evolving from childhood with a common denominator: combustion-derived nanoparticles 
potentially including atmospheric nanocluster aerosols. 5, 75 Since the olfactory bulb is an 
early target and hTau is a prime actor, olfactory testing should be done along with early 
cognitive and behavioral testing to identify subjects at high neurodegenerative risk. APOE 
4 carriers should start neuroprotective interventions in the first two decades of life. 
A key challenge is to define clinical, laboratory, imaging, and cognitive non-
invasive markers for the initial stages of the evolving complex tautopathies and alpha-
synucleinopathies. It is imperative that we understand the earliest neuropathological 
changes upon exposures to air pollutants, the complexity of the interaction between sources 
and characteristics of pollutants and the ultimate CNS manifestations which will vary with 
age, nutritional, metabolic and genetic interactions. 
 Early interventions should be integrated in health and educational agendas along with 
identifying early gender-specific risk trajectories. We are certain air pollution should be 
included as an early risk factor in the research priorities to reduce global burden of 
dementia, ignoring the subject is not in the best interest of millions of exposed people. 
Pollution control should be prioritized, and supporting research related to air pollution and 
pediatric, teens and young adults neurodegenerative impact ought to be a goal in our 
prevention efforts to stop these diseases. Screening for olfaction deficits early in life, 
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certainly in the first 2 decades of life would help to define cohorts at highest risk and 
provide mechanistic insights into major neurodegenerative fatal diseases including 
Alzheimer and Parkinson’s. Preventive medicine ought to be our goal and we must consider 
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Figure 1 
Cumulated PM2·5 trends of the annual, averaged over 3 years, mean concentrations in 
excess the USAEPA standard for 179 individuals according to their age at the time of death 
and residential location. The regressions are overlapped on a map showing the spatial 
distribution of the annual PM2·5 concentrations for the base year 2008 (the last year of the 5 
year study). The map in the upper right corner shows the spatial distribution of the annual 
average of the daily ozone 8-h maximum for 2008.  
Figure 2  
Percentages of hTau stages as defined by Braak et al., 43-45 in subcortical and cortical stages 
in previous study.20  Data compared to olfactory bulb percentages of hTau NTs (neurites) 
and NFTs (neurofibrillary tangles), and ɑ-synuclein (OB ɑ-Syn) 38-40  in the same subjects 
by  age: 0-20 and 21-40 years at the time of death.  
Brain Htau Stage 43-45: 0=absent, 1= pretangle stages a-c, 2= pretangle stages 1a, 1b, 3=NFT stages 
I, II, 4=NFT stages III-IV, 5=NFT stages V-VI  
Olfactory bulb: Htau scores NTs and NFTs separately: 0=absent, 0.5=very mild, only singly 
lesions, 1=mild,    2=moderate, 3=severe.38, 39  
ɑ-Synuclein scores: 0=absent, 1: mild, sparce Lewy neurites or Lewy bodies, 2:moderate, more than 
1 Lewy body in a low power field (LPF) and sparce LNs, 3:severe >1 LBs and scattered LNs in a 
LPF, 4: very severe, numerous LNs and LBs according to the templates published by the Dementia 








Representative immunohistochemistry (IHC) and H&E sections from children in the first 
decade of life.  
 A. Two year old male APOE 3/3, olfactory bulb 7 µm thick section. The anatomical 
organization of the olfactory bulb is still intact and the different layers could be defined: 
GL glomerular layer, ML mitral layer and GRANL granular cell layer. The olfactory tract 
(OT) is unremarkable. H&E, Scale bar 200 µm 
B. Same child as A. Higher power shows focal disorganization of the OB architecture with 
isolated mitral neurons (arrow) H&E, Scale bar 100 µm. INSERT: Olfactory tract isolated 
cells showed abundant particulate material. H&E, Scale bar 10µm 
C. Three year old APOE 3/3. Glomeruli are abundant, with significant variation in size. 
Abnormal blood vessels with no visible lumen are seen throughout the sample (arrow). 
H&E, Scale bar 50µm 
D. Same child as C. Glomerular layer showed numerous immunoreactive (IR) amyloid β 
cells (brown product). IHC x Aβ counterstained with H, Scale bar 100µm.INSERT: Higher 
power to show glomerular and periglomerular cells with cytoplasmic IR to Aβ. Scale bar 10 
µm 
E. Glomerular (g) region shows isolated hTau IR in axon initial segment (AIS) (arrow), 




F. Granular cell layer, same child as E showing one hTau positive aggregated IR in axon 
initial segment (AIS).  IHC xAT8 Scale bar 40µm 
G. Same child as C with ɑ-Synuclein IR in glomerular region. IHC x ɑ-Syn phosphorylated 
at Ser-129, LB509, Scale bar 10µm 
H. An isolated glomerular immunoreactive (IR) area to amyloid β. ICH x Aβ, Scale bar 50 
µm 
Figure 4 
Representative immunohistochemistry (IHC) and H&E sections from children and young adults in 
the second decade of life.  
A. Eleven year old boy APOE 3/3. The laminar organization of the olfactory bulb is 
still visible (glomerular layer, GL), but the different layers are ill-defined. There is 
significant variation in the glomeruli size (g) and blood vessels are prominently seen 
(arrows).H&E, Scale bar 100 µm 
B. A close-up of the glomerular region (g) to show the presence of abnormal blood 
vessels with significant reduction in their lumen (arrowheads). H&E, Scale bar 50 
µm 
C. Close-up of an abnormal blood vessel in glomerular region. Notice a 
polymorphonuclear leucocyte (arrow) attached to the vessel wall, and the 
vacuolated endothelial cells (arrowhead). H&E Scale bar 50 µm 
D. Diffuse amyloid plaques are seen throughout the OB layers (arrow). IHC x Aβ 
counterstained with H, Scale bar 100µm. 
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E. Same child as C with extensive Aβ IR deposits of different sizes in the olfactory 
tract (arrow) IHC x Aβ counterstained with H, Scale bar 100µm.INSERT: Upper 
left, discrete isolated diffuse Aβ plaques and upper right Aβ IR in larger arterial 
vessels in the arachnoidal space.  
F. Eleven year old boy (same as A) with extensive ɑ-Synuclein IR in glomerular 
region. IHC x ɑ-Syn, LB509, red product, Scale bar 50µm 
G. The glomerular region is a target for accumulation of particulate material. Several 
cells within the glomerulus and outside are packed with particles (arrows). H&E, 
Scale bar 10 µm 
H. Fourteen year old boy APOE 3/3 with striking variation in glomeruli size, some (g) 
are basically amorphous, without visible nuclei and very small and irregular. H&E, 
Scale bar 50 µm. INSERT: This child had moderate hTau neurites.  IHC xAT8 
Scale bar 10µm 
I. Seventeen year old boy APOE 3/3 with a significant abnormal laminar organization 
of the olfactory bulb and poor definition of the different layers (granular layer,left). 
The glomeruli region (right side of the picture) shows very amorphous and pale 
glomeruli. H&E, Scale bar 10 µm 
J. Same 17y old boy as in I to show a glomerulus with an area of metaplastic 
calcification (framed in a square). H&E, Scale bar 20 µm 
K. Same teen as J,I. Extensive IR to ɑ-synuclein. Neuronal perikaryal inclusions 




L. Twenty year old young man APOE 3/4. Numerous amyloid β diffuse plaques 
scattered throughout the specimen (arrows). IHC x Aβ counterstained with H, Scale 
bar 200µm 
M. Same subject as L. Severe disorganization of the laminar normal architecture with 
the glomerular region showing few and amorphous, small glomeruli (g), few 
clusters of mitral neurons (arrows) and a thin granular cell layer (GRANL). H&E, 
Scale bar 50µm 
N. Glomerular layer in the 20 y old APOE 3/4 subject. Nuclear Htau was significant in 
this subject and few small Htau plaques (head arrow). IHC xAT8 Scale bar 50µm 
O. Same subject as N to show the glomerular region stained for Htau and 
counterstained with H. There is strong nuclear Htau IR and cytoplasmic, granular 
Htau in the perikaryon of a periglomerular cell (headarrow).Notice the longitudinal 
segment of a blood vessel (BV) in close proximity to the central glomerulus. We 
marked the enlarged Virchow-Robin space with (*). 
P. The anterior olfactory nucleus in this 20y old male APOE 3/4 shows extensive 
nuclear Htau(arrows)  but no IR with either NTs or NFTs. IHC xAT8 Scale bar 
50µm 
Q. Abeta in AON 
R. The same young man shows extensive IR to ɑ-synuclein in the glomerular layer. 
Neuronal perikaryal inclusions (arrows) are abundant. IHC x ɑ-Syn, LB509, red 







Representative immunohistochemistry and H&E sections from subjects in the third and 
fourth decades of life.  
A. Thirty two year old female, APOE 4/4. Olfactory tracts of APOE4 carriers were 
characterized by extensive deposition of corporae amylacea (CA) and severe 
rarefaction of white matter tracts. H & E, Scale bar 100 µm 
B. Same subject as A olfactory bulb in the region of the anterior olfactory nucleus 
(AON), massively occupied by corporae amylacea. H & E, Scale bar 100 µm 
C. Higher power of the AON area to show the corporae amylacea deposition (H&E 
Scale bar 50 µm) and the presence of astrocytes with hyperchromatic, convoluted 
nuclei (arrowhead) containing CA in their cytoplasm. INSERT: abnormal astrocyte 
with large CA, note the abnormal surrounding neuropil. H&E Scale bar 10 µm. 
D. APOE 4 carrier, the glomeruli (g) are very small and amorphous. A few mitral 
neurons remain (arrows). H&E Scale bar 50 µm 
E. Twenty-five year old male, APOE 3/4, suicide, anterior olfactory nucleus AON 
completely occupied by corporae amylacea CA. H & E, Scale bar 50 µm  
F. Forty year old male, APOE 3/3 moderate hTau NTs (arrowheads) and 
NFTs(arrows) in glomerular layer IHC xAT8 Scale bar 20µm 
G. Thirty nine year old male, hTau NTs (arrows) and NFT(arrowhead) in granular 
layer IHC xAT8 Scale bar 10µm 
H. Same subject as G to show hTau NFTs and NTs in granular cell layer. IHC xAT8 
Scale bar 10µm 
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I. Twenty-eight year old female, APOE 3/4 (#106 in the Table 1 Suppl). Extensive IR 
ɑ-synuclein LNs.  IHC x ɑ-Syn, LB509, brown product, Scale bar 50µm. INSERT 
LEFT: Neuronal perikaryal inclusions are also seen. INSERT RIGHT: Enlarged IR 
neurites are common.  Both inserts: IHC x ɑ-Syn, LB509, red product, Scale bar 
10µm 
J. Twenty-seven year old male, APOE 3/4 (#97 in the Table 1 Suppl). Neuronal 
perikaryal ɑ-synuclein IR (arrows) and neurites(arrowheads). IHC x ɑ-Syn, LB509, 
brown product, Scale bar 10µm 
K. Twenty-seven year old male, APOE 3/3 with a CPM2.5 of 2303 µg/m3 has no 
identifiable AON neurons, a few cells have IR to amyloid β (arrows) and an isolated 
diffuse amyloid plaque (arrowhead). IHC x Aβ counterstained with H, Scale bar 
100µm. INSERT: Aβ IR arteriole. Scale bar 10µm 
 
Figure 6 
Representative 1µm toluidine blue and electron micrographs pictures. 
A. Fourteen year old girl APOE 3/3. Blood vessel basement membranes are focally 
thick (arrowhead), mild enlargement of the Virchow-Robin space (*) is noted 
and there is a significant loss of both myelinated(arrows) and unmyelinated 
axons. A few myelinated axons remain in the olfactory tract (arrows). Toluidine 
blue, Scale bar 10µm 
B. Same 14 year old as A, section of mitral tufted cell layer. Few small myelinated 
axons remain and unmyelinated axons are difficult to identify. Small clusters of 
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thin myelinated axons marked by short arrows and mitral neurons by longer 
arrows.. Toluidine blue, Scale bar 10µm 
C. Olfactory bulb in a 17 year old male APOE 3/3. Numerous Lipofuscin (Lf) 
granules are seen. Red blood cells in the lumen of the vessels are marked RBC. 
Scale bar 2 µm 
D. A close-up of a cluster of Lipofuscin granules in the cytoplasm of an endothelial 
cell. Scale bar 200 nm. 
E. Endothelial cells exhibit extensive deposit of lipofuscin and RBC are in close 
contact with endothelial cells (EC). Scale bar 500 nm. 
F. Fourth teen year old girl with beta pleaded sheet helicoidal conformation fibers 
in the cytoplasm of an endothelial cell (EC) (lower half of the picture). 
Numerous CDNPs are seen in the EC nucleus and in the EC cytoplasm (arrows). 
Lf marks lipofuscin in close contact with the nucleus of the endothelial cells. 
Scale bar 500 nm 
G. Seventeen year old male APOE 3/4.  The endothelial cells of small blood 
vessels are involved in active erytrophagocitosis (square frame). Scale bar 2 µm 
H. A close-up shows the square frame from G: one red blood cell (RBC) is 
surrounded by a membranous lysosomal structure in an endothelial cell (EC). 
The nucleus(N) of the EC is closed to the lysosomal structure. Scale bar 500 nm 
I. Same 17y old subject as C. The endothelial cell is phagocytizing a cellular non-
identified fragment also containing numerous NPs (arrowhead). NPs are marked 
with a long arrows. The * marks apparently empty EC vacuoles. RBC are seen 
in the lumen of the vessel. Scale bar 500 nm 
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J. Capillaries are commonly occupied with red blood cells (RBC) containing 
significant amounts of NPs that orient themselves in a line between them 
(arrowhead). Scale bar 500 nm 
K. A capillary in a 15 year old male. The NPs are also seen mostly between 2 RBC 
(arrowheads). Interestingly, a lipofuscin (Lf) early granule in the endothelial 
cytoplasm (EC) shows a rim of NPs (black arrowhead). Scale bar 500 nm 
Figure 7 
Representative 1µm toluidine blue and electron micrographs pictures. 
A. Fourteen year old girl APOE 3/3 medium size blood vessel in lower portion of 
picture. Several myelinated axons of different caliber, all show focal 
fragmentation of myelin and clusters of particles (arrowheads). Empty spaces in 
the neuropil are marked (*) and one isolated combustion-derived nanoparticle is 
marked (arrow). Scale bar 2 µm 
B. Twenty-four year old male APOE 3/3. Capillaries with hyperplastic endothelial 
cells (*) are surrounded by a glial cell (arrow heads). Scale bar 2 µm 
C. Same subject, an oligodendrocyte (arrow) is surrounded by a few abnormal 
myelinated axons, some with very thin myelin (arrowhead, lower right). Scale 
bar 2 µm 
D. A close-up of the oligodendrocyte to show abnormal nuclear membrane pores 
and NPs inside the nucleus (upper arrow). NPs are also present in the cytoplasm 
(lower left arrow) and mitochondria (M) are abnormal. Lipofuscin granules are 
also present in the cytoplasm (Lf). Scale bar 500 nm 
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E. A higher power of D to show the relationship between the dilated endoplasmic 
reticulum (ER) and the lysosomal Lf structure. The short arrow points to the 
space between the ER and the Lf. The larger arrow points to the proximity 
between the mitochondria and the ER. Scale bar 500 nm 
F. Twenty year old male APOE 3/3. Mitochondria in unmyelinated axons contain 
combustion-derived nanoparticles (right arrow). Elsewhere, NPs are seen in 
severely damaged unmyelinated axons (left arrow). Empty dendrite-like 
structures are marked (*). Scale bar 500 nm 
G. A common finding in between unmyelinated axons was the presence of clusters 
of nanoparticles (arrows). Empty structures are common (*).Scale bar 500 nm 
H. A severely abnormal dendrite with a combustion-derived nanoparticle 
(arrowhead). Scale bar  nm 
I. Nanoparticles are seen inside dendrites and unmyelinated axons (arrows). Scale 
bar nm 
J. Empty structures and abnormal mitochondria with combustion-derived particles 
are ubiquitous. Scale bar  nm 
 
 
 
 
